- Email: [email protected]
4145410 Method of preparing a controlled-release pharmaceutical preparation, and resulting composition
Gen. Pharmac. Vol. 16, No. 1, pp.i-xxii, 1985 Pergamon Press Ltd. Printed in Great Britain
NEW PATENTS This Section contains abstracts and, where appropriate, illustrations of recently issued United States patents and published patent applications filed from over 30 countries under the Patent Cooperation Treaty. This information was obtained from recent additions to the Pergamon PATSEARCH®online database in accordance with interest profiles developed by the Editors. Further information about Pergamon PATSEARCH® can be obtained from Pergamon InfoLine Inc., 1340 Old Chain Bridge Road, McLean, Virginia 22101 U.S.A. Copies of complete patents announced in this Section are available from Pergamon InfoLine Inc. for $8 per copy. Payment with order is required. Orders outside North America add $2 for air postage. Order by patent number for Pergamon InfoLine only. of aminobenzoic acid, represented by the following general formula: See Patent for Chemical Structure wherein R 1 denotes one member selected from the group consisting of the residual groups formed by removing OH at l(alpha)-or 1(beta) position from arabinose, xylose, rhamnose, glucose, galactose, mannose and fructose, and R2 is a hydrogen atom, an alkyl group of one to four carbon atoms or a pharmaceutically acceptable metal, and (b) a pharmaceutically acceptable carrier or diluent of (a) is disclosed.
4145410 METHOD OF PREPARING A CONTROLLED-RELEASE PHARMACEUTICAL PREPARATION, AND RESULTING COMPOSITION Barry Sears A method of preparing a controlled-release pharmaceutical compound for Oral Administration, which pharmaceutical compound is subject to Enzymatic Hydrolysis on Oral Administration, which method comprises encapsulating the pharmaceutical compound with a synthetic phosphatidyl compound having a Modified Polarhead Moiety which increases the resistance of the phosphatidyl compound to Phospholipase C Hydrolysis.
4440759 20-AMINO TYLOSIN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
4440757
Satoshi Omura, Akira Nakagawa, Setagaya ku, Tokyo, Japan
PHARMACEUTICAL COMPOSITION COMPRISING DERIVATIVE OF AMINOBENZOIC ACID FOR REGULATING PROSTAGLANDIN
0
Chikao Yoshikumi, Yoshio Ohmura, Fumio Hirose, Masanori Ikuzawa, Kenichi Matsunaga, Takayoshi Fujii, Minoru Ohhara, Takao Ando, Kunitachi, Japan assigned to Kureha Kagaku Kogyo Kabushiki Kaisha
CH~
"
COOR2
~
o
o
CH30Q
NH--R 1 ~N
A pharmaceutical composition for regulating prostagrandins, which comprises (a) a derivative
o.P.t6/l--F
CH3\ //~CH2~CH2~X
N~R 12 N../
i
NEW PATENTS This Section contains abstracts and, where appropriate, illustrations of recently issued United States patents and published patent applications filed from over 30 countries under the Patent Cooperation Treaty. This information was obtained from recent additions to the Pergamon PATSEARCH®online database in accordance with interest profiles developed by the Editors. Further information about Pergamon PATSEARCH® can be obtained from Pergamon InfoLine Inc., 1340 Old Chain Bridge Road, McLean, Virginia 22101 U.S.A. Copies of complete patents announced in this Section are available from Pergamon InfoLine Inc. for $8 per copy. Payment with order is required. Orders outside North America add $2 for air postage. Order by patent number for Pergamon InfoLine only. of aminobenzoic acid, represented by the following general formula: See Patent for Chemical Structure wherein R 1 denotes one member selected from the group consisting of the residual groups formed by removing OH at l(alpha)-or 1(beta) position from arabinose, xylose, rhamnose, glucose, galactose, mannose and fructose, and R2 is a hydrogen atom, an alkyl group of one to four carbon atoms or a pharmaceutically acceptable metal, and (b) a pharmaceutically acceptable carrier or diluent of (a) is disclosed.
4145410 METHOD OF PREPARING A CONTROLLED-RELEASE PHARMACEUTICAL PREPARATION, AND RESULTING COMPOSITION Barry Sears A method of preparing a controlled-release pharmaceutical compound for Oral Administration, which pharmaceutical compound is subject to Enzymatic Hydrolysis on Oral Administration, which method comprises encapsulating the pharmaceutical compound with a synthetic phosphatidyl compound having a Modified Polarhead Moiety which increases the resistance of the phosphatidyl compound to Phospholipase C Hydrolysis.
4440759 20-AMINO TYLOSIN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
4440757
Satoshi Omura, Akira Nakagawa, Setagaya ku, Tokyo, Japan
PHARMACEUTICAL COMPOSITION COMPRISING DERIVATIVE OF AMINOBENZOIC ACID FOR REGULATING PROSTAGLANDIN
0
Chikao Yoshikumi, Yoshio Ohmura, Fumio Hirose, Masanori Ikuzawa, Kenichi Matsunaga, Takayoshi Fujii, Minoru Ohhara, Takao Ando, Kunitachi, Japan assigned to Kureha Kagaku Kogyo Kabushiki Kaisha
CH~
"
COOR2
~
o
o
CH30Q
NH--R 1 ~N
A pharmaceutical composition for regulating prostagrandins, which comprises (a) a derivative
o.P.t6/l--F
CH3\ //~CH2~CH2~X
N~R 12 N../
i